< Back to latest news & events

Event

ONE Life Sciences Leadership Forum 6

September 2020

Event date: 1st September 2020

The sixth ONE Life Sciences Leadership Forum will explore intellectual property and clinical pathway strategies.

HGF Partner Craig Thomson, Senior Trade Mark Attorney Caroline Pigott and CEO of clinical trials management company Afortiori Development Nicola Wall will host the session, where they will investigate how to manage the complex and costly challenges of pursuing IP protection for your technology and growing brand, setting up a clinical pathway and secure marketing approval for the product.

This session will explore how to bring these challenges into a coordinated strategy specifically designed to support each other, as well as the broader commercial goals of your company, such as raising investment. It will also include an interactive discussion, work through a scenario based on real-life situations and guidance on how to apply the lessons learned.

Register now

Attendees

Craig
Thomson

Caroline
Pigott

Latest updates

Exam Success!

HGF are delighted to announce success for many of our colleagues in the recent exams on becoming qualified attorneys and would like to congratulate them on this fantastic achievement. Martyn …

Read article

In2ScienceUK continues to promote diversity and inclusion in STEM and IP with its award winning programme

HGF are proud sponsors of In2ScienceUK, a charity that gives young people from low-income backgrounds the opportunity to gain essential insights into science, technology, engineering, and mathematics (STEM) careers with …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article
See all updates
< Back to latest news & events

Event

ONE Life Sciences Leadership Forum 6

September 2020

Event date: 1st September 2020

The sixth ONE Life Sciences Leadership Forum will explore intellectual property and clinical pathway strategies.

HGF Partner Craig Thomson, Senior Trade Mark Attorney Caroline Pigott and CEO of clinical trials management company Afortiori Development Nicola Wall will host the session, where they will investigate how to manage the complex and costly challenges of pursuing IP protection for your technology and growing brand, setting up a clinical pathway and secure marketing approval for the product.

This session will explore how to bring these challenges into a coordinated strategy specifically designed to support each other, as well as the broader commercial goals of your company, such as raising investment. It will also include an interactive discussion, work through a scenario based on real-life situations and guidance on how to apply the lessons learned.

Register now

Attendees

Craig
Thomson

Caroline
Pigott

Latest updates

Exam Success!

HGF are delighted to announce success for many of our colleagues in the recent exams on becoming qualified attorneys and would like to congratulate them on this fantastic achievement. Martyn …

Read article

In2ScienceUK continues to promote diversity and inclusion in STEM and IP with its award winning programme

HGF are proud sponsors of In2ScienceUK, a charity that gives young people from low-income backgrounds the opportunity to gain essential insights into science, technology, engineering, and mathematics (STEM) careers with …

Read article

Spotting innovation in digital health – and can you patent it?

Intellectual Property (IP) can add significant value to your business, providing a competitive edge over the market, as well as demonstrating sound business planning to help secure investment. There are …

Read article

Innovation at the heart of UK medtech strategy

The UK Department of Health and Social Care has recently published the government’s first ever medical technology strategy in an effort to accelerate access to innovative technologies. The strategy document …

Read article

How medtech start-ups can supercharge their IP for fundraising

Why is IP important for fundraising? Intellectual property (IP) rights underpin the value of most medtech start-up companies. IP rights include patents, design rights, trade marks, copyright and trade secrets …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article
See all updates